1

Recordati

#1507

Rank

$11.85B

Marketcap

IT Italy

Country

Recordati
Leadership team

Dr. Robert Koremans M.D. (CEO & Director)

Ms. Cathrin Petty (Exec. Director)

Mr. Giampiero Mazza (Exec. Director)

Products/ Services
Biotechnology, Health Care, Manufacturing
Number of Employees
1,000 - 20,000
Headquarters
Lebanon, New Jersey, United States
Established
1926
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
REC.MI
Social Media
Overview
Location
Summary
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.
History

Recordati was founded in 1926 by Dr Carlo Recordati, an Italian pharmaceutical entrepreneur. It started out as a small manufacturer of drugs and soon expanded its offering. In the 1970s, the company went public and listed on the Italian Stock Exchange in 1985.

Mission
Recordati’s mission is to provide high-quality medications to its patients, providing innovative and cost-effective solutions to patients’ needs.
Vision
Recordati’s vision is to be a leading global player in the pharmaceutical industry, offering innovative, safe and effective treatments, centered on the highest standards of patient care.
Key Team

Mr. Giorgio De Palma (Exec. Director)

Mr. Luigi Felice La Corte (Group CFO & Exec. Director)

Ms. Federica De Medici (Director of Investor Relations & Corp. Communications)

Mr. Giovanni Minora (Group Audit & Compliance)

Ms. Daria Ghidoni (Group Gen. Counsel)

Mr. Giuseppe Gualazzini (Sr. VP of Group HR)

Mr. Gabriele Finzi (Exec. VP of Corp. Devel. & Licensing)

Recognition and Awards
Recordati has won several awards over the years, including awards for innovation, corporate social responsibility and customer satisfaction. The Company has also been recognised numerous times for its contribution to the Italian economy and its commitment towards research and innovation.
References
Recordati
Leadership team

Dr. Robert Koremans M.D. (CEO & Director)

Ms. Cathrin Petty (Exec. Director)

Mr. Giampiero Mazza (Exec. Director)

Products/ Services
Biotechnology, Health Care, Manufacturing
Number of Employees
1,000 - 20,000
Headquarters
Lebanon, New Jersey, United States
Established
1926
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
REC.MI
Social Media